Clear Search

Showing 1 result for “Álvaro Gracia JM”.

April 2022

Alcançando o controle da dor em artrite reumatoide precoce: baricitinib monoterapia ou em combinação com metotrexato em comparação a metotrexato monoterapia

RMD Open. 2022;8(1):e001994 doi: 10.1136/rmdopen-2021-001994

Post hoc analysis of the RA-BEGIN trial finds that, over a one-year period, patients treated with baricitinib (monotherapy or in combination with methotrexate [MTX]) report greater pain relief and a more rapid attainment of clinically meaningful thresholds of pain improvement, than patients who receive MTX monotherapy.Often overlooked, when treating RA solely to a disease activity target, patient-reported pain is common in RA, even in those reaching inflammatory remission. The fact that pain per...